Educational only — not medical advice, not a diagnosis. This page describes what users commonly discuss with their licensed healthcare provider around this topic. We do not diagnose, treat, cure, reverse, or fix any condition. No compound listed is recommended. Work with a licensed clinician for any decision.
Home/Conditions/Chronic Low-Grade Inflammation
INFLAMMATION — EDUCATIONAL GUIDE

Chronic Low-Grade Inflammation

The persistent low-level inflammatory pattern linked to cardiovascular, metabolic, and cognitive disease — trackable via specific markers.

What This Is

Chronic low-grade inflammation is a shared mechanism across most non-communicable disease — cardiovascular disease, metabolic disease, cognitive decline, many cancers. Unlike acute inflammation (injury, infection), chronic low-grade inflammation is persistent, subclinical, and often silent until downstream damage appears.

hs-CRP is the most widely used single marker. Values <1 mg/L are low-risk; 1–3 average; >3 elevated. Other markers (IL-6, TNF-α) are more specialized. Caveats: hs-CRP rises with acute infection or hard training within 48 hours — don't draw during either.

Lifestyle levers (adiposity reduction, training volume calibration, sleep, dental health, gut health) have meaningful literature support. Pharmacologic approaches are your clinician's call.

Biomarkers Users Commonly Track

The following lab markers are commonly discussed with a licensed provider in this context. They are not a diagnostic checklist. Only your clinician can interpret what these values mean for your specific situation.

hs-CRP<1.0 mg/L — often <0.5 mg/L in highly optimized individuals
Most common marker of systemic chronic inflammation. Rises 48h after training — time draws carefully.
Ferritin70–150 ng/mL is a common optimization target
Acute-phase reactant. Elevation can reflect inflammation rather than iron overload.
GGT<25 U/L (men) · <20 U/L (women)
Liver enzyme also sensitive to oxidative stress.
Homocysteine<8 mcmol/L for cardiovascular and cognitive optimization
Methylation + inflammation marker often elevated together.

Compounds Users Research (Ask Your Clinician)

No compound below is a recommended treatment. These are research-stage or investigational compounds that users commonly look up in this context. Any decision about their use is a conversation with a licensed healthcare provider, under their supervision, with full understanding of risks and your personal history.
BPC-157
Users researching systemic repair often discuss with their provider — research-stage.
TB-500
Healing-focused peptide some users research; clinician supervision recommended.
Thymosin Alpha-1
Immune-modulating peptide with published clinical use in specific infection contexts — under clinician supervision.

Related Reading

Related Conditions

Elevated ApoB (Cardiovascular Risk)Poor Recovery / Overtraining
Bring the data to your next visit.

MyProtocolStack lets you log the biomarkers on this page across lab draws, chart the trend, and hand a structured report to your clinician. Better conversations start with better data. We do not replace your provider; we help you show up prepared.

Start tracking free →
Compliance notice: This page is informational and educational only. MyProtocolStack does not provide medical advice, diagnosis, or treatment. All references to biomarkers are educational. All references to compounds describe what users research and typically discuss with their clinician — not endorsements or treatment recommendations. Reference ranges vary by laboratory. Symptom interpretation and any protocol decisions require a licensed healthcare provider. If you are experiencing symptoms, consult your clinician.